Combined chondrocyte-copolymer implantation with slow release of basic fibroblast growth factor for tissue engineering an auricular cartilage construct

Journal of Biomedical Materials Research - Part A

Volumn 74, Issue 3, 2005, Pages 408-418

  Isogai, Noritaka ^a   Morotomi, Tadaaki ^a   Hayakawa, Sumio ^a   Munakata, Hiroshi ^a   Tabata, Yasuhiko ^b   Ikada, Yoshito ^c   Kamiishi, Hiroshi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Auricular chondrocyte; Basic fibroblast growth factor; Poly(L lactide caprolactone); Tissue engineering

Indexed keywords

BIOMEDICAL ENGINEERING; CARTILAGE; CELLS; COPOLYMERS; GROWTH KINETICS; TISSUE CULTURE;

ARTICULAR CHRONDROCYTE; BASIC FIBROBLAST GROWTH FACTOR; POLY(L-LACTIDE-EPSI;-CAPROLACTONE); TISSUE ENGINEERING;

IMPLANTS (SURGICAL);

BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN TYPE 2; COPOLYMER; GELATIN; POLYLACTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; CHONDROGENESIS; CONTROLLED STUDY; DOG; DRUG RELEASE; EAR CARTILAGE; EVALUATION; GENE EXPRESSION; IMPLANTATION; IN VIVO STUDY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; POSTOPERATIVE PERIOD; TISSUE ENGINEERING;

ANIMALS; APOPTOSIS; CARTILAGE; CHONDROCYTES; DELAYED-ACTION PREPARATIONS; DOGS; EAR, EXTERNAL; FIBROBLAST GROWTH FACTOR 2; GELATIN; GENE EXPRESSION PROFILING; HUMANS; IMPLANTS, EXPERIMENTAL; MICE; MICROSPHERES; POLYESTERS; TISSUE ENGINEERING;

EID: 23744489998     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30343     Document Type: Article

References (45)

1. Tanzer RC. Total reconstruction of the external ear. Plast Reconstr Surg 1959;23:1-15.
2. Nagata S. Microtia: auricular reconstruction. In: Achauer BM, Eriksson E, Vander Kolk CA, Coleman JJ, Russell RC, Guyuron B, editors. Plastic surgery: indications, operations and outcomes. Vol 2. St. Louis: Mosby; 2000. Chapter 66, p 1023-1056.
3. Hata Y, Hosokawa K, Yano K, Matsuka K, Ito O. Correction of congenital microtia using the tissue expander. Plast Reconstr Surg 1989;84:741-751.
4. Hata Y, Umeda T. Reconstruction of congenital microtia by using a tissue expander. J Med Dent Sci 2000;47:105-116.
5. Ishikura N, Shimada K, Yoshida J. Newly developed surgical procedure for ear reconstruction using tissue expansion in patients with microtia. Faces 1998;6:69-78.
6. Fukuda O, Yamada A. Reconstruction of the microtic ear with autogenous cartilage. Clin Plast Surg 1978;5:351-366.
7. Ohara K, Nakamura K, Ohta E. Chest wall deformities and thoracic scoliosis after costal cartilage graft harvesting. Plast Reconstr Surg 1997;99:1030-1036.
8. Brent B. Auricular repair with autogenous rib cartilage grafts: two decades of experience with 600 cases. Plast Reconstr Surg 1992;90:355-374.
9. Cao Y, Vacanti JP, Paige KT, Upton J, Vacanti CA. Transplantation of chondrocytes utilizing a polymer-cell construct to produce tissue-engineered cartilage in the shape of a human ear. Plast Reconstr Surg 1997;100:297-302.
10. Kamil SH, Kojima K, Vacanti MP, Bonassar LJ, Vacanti CA, Eavey RD. In vitro tissue engineering to generate a humansized auricle and nasal tip. Laryngoscope 2003;113:90-94.
11. Isogai N, Asamura S, Ikada Y, Morita S, Hillyer J, Janquet R, Landis WJ. Tissue engineering of an auricular model utilizing cultured chondrocyte-poly(L- lactide-ε-caprolactone) scaffolds. Tissue Eng 2004;10:673-687.
12. Sah RL, Trippel SB, Grodzinsky AJ. Differential effects of serum, insulin-like growth factor-1, and fibroblast growth factor-2 on the maintenance of cartilage physical properties during long-term culture. J Orthop Res 1996;14:44-52.
13. Nixon AJ, Lillish JT, Mohammed HO. Differentiated cellular function in fetal chondrocytes cultured with insulin-like growth factor-1 and transforming growth factor-beta. J Orthop Res 1998;16:531-541.
14. Koch RJ, Gorti GK. Tissue engineering with chondrocytes. Facial Plast Surg 2002;18:59-68.
15. Whalen GF, Shing Y, Folkman J. The fate of intravenously administered bFGF and the effect of heparin. Growth Factors 1989;1:157-164.
16. Arevalo-Silva CA, Cao Y, Vacanti M, Weng Y, Vacanti CA, Eavey RD. Influence of growth factors on tissue-engineered pediatric elastic cartilage. Arch Otolaryngol Head Neck Surg 2000;126:1234-1238.
17. Arevalo-Silva CA, Cao Y, Weng Y, Vacanti M, Rodriguez A, Vacanti CA, Eavey RD. The effect of fibroblast growth factor and transforming growth factor-beta on porcine chondrocytes and tissue-engineered autologous elastic cartilage. Tissue Eng 2001;7:81-88.
18. Kamil SH, Aminuddin BS, Bonassar LJ, Silva CA, Weng Y, Woda M, Vacanti CA, Eavey RD, Vacanti MP. Tissue-engineered human auricular cartilage demonstrates euploidy by flow cytometry. Tissue Eng 2002;8:85-92.
19. 131I-labeled human growth hormone of high specific radioactivity. Biochem J 1963;89:114-123.
20. Klagsbrun M. Large-scale preparation of chondrocytes. Methods Enzymol 1979;58:560-564.
21. Tabata Y, Hijikata S, Ikada Y. Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels. J Controlled Release 1994;31:189-199.
22. Gospodarowicz D. Localization of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature 1974;249:123-127.
23. Abraham JA, Whang JL, Tumolo A, Mergia A, Friedman J, Gospodarowicz D, Fiddes JC. Human basic fibroblast growth factor: nucleotide sequence and genomic organization. EMBO J 1986;10:2523-2528.
24. Cuevas P, Burgos J, Baird A. Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo. Biochem Biophys Res Commun 1988;156:611-618.
25. Kato Y, Iwamoto M. Fibroblast growth factor is an inhibitor of chondrocyte terminal differentiation. J Biol Chem 1990;265: 5903-5909.
26. Iwamoto M, Jikko A, Murakami H, Shimazu A, Nakashima K, Iwamoto M, Takigawa M, Baba H, Suzuki F, Kato Y. Changes in parathyroid hormone receptors during chondrocyte cytodifferentiation. J Biol Chem 1994;269:17245-17251.
27. Quatela VC, Sherris DA, Rosier RN. The human auricular chondrocyte. Responses to growth factors. Arch Otolaryngol Head Neck Surg 1993;119:32-37.
28. Saadeh PB, Brent B, Mehrara BJ, Steinbrech DS, Ting V, Gittes GK, Longaker MT. Human cartilage engineering: chondrocyte extraction, proliferation, and characterization for construct development. Ann Plast Surg 1999;42:509-513.
29. Masaki I, Yonemitsu Y, Yamashita A, Sata S, Tanii M, Komori K, Nakagawa K, Hou X, Nagai Y, Hasegawa M, Sugimachi K, Sueishi K. Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circ Res 2002;90:966-973.
30. Onimaru M, Yonemitsu Y, Tanii M, Nakagawa K, Masaki I, Okano S, Ishibashi H, Shirasuna K, Hasegawa M, Sueishi K. Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated downregulation in ischemic limbs. Circ Res 2002;91:923-930.
31. Ikada Y, Tabata Y. Protein release from gelatin matrices. Adv Drug Delivery Rev 1998;31:287-301.
32. Tabata Y, Nagano A, Ikada Y. Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng 1999; 5:127-138.
33. Guo JF, Jourdian GW, MacCallum DK. Culture and growth characteristics of chondrocytes encapsulated in alginate beads. Connect Tissue Res 1989;19:277-297.
34. Blanco FJ, Ochs RL, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995;146:75-85.
35. Notoya K, Jovanovic DV, Reboul P, Martel-Pelletier J, Mineau F, Pelletier JP. The induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2. J Immunol 2000;165:3402-3410.
36. Aizawa T, Kon T, Einhorn TA, Gerstenfeld LC. Induction of apoptosis in chondrocytes by tumor necrosis factor-alpha. J Orthop Res 2001;19:785-796.
37. Kuhn K, Hashimoto S, Lotz M. Cell density modulates apoptosis in human articular chondrocytes. J Cell Physiol 1999; 180:439-447.
38. Kuhn K, Lotz M. Regulation of CD95 (Fas/APO-1)-induced apoptosis in human chondrocytes. Arthritis Rheum 2001;44: 1644-1653.
39. Lotz M, Hashimoto S, Kuhn K. Mechanisms of chondrocyte apoptosis. Osteoarthritis Cartilage 1999;7:389-391.
40. Hirsch MS, Lunsford LE, Trinkaus-Randall V, Svoboda KK. Chondrocyte survival and differentiation in situ are integrin mediated. Dev Dyn 1997;210:249-263.
41. Cao L, Lee V, Adams ME, Kiani C, Zhang Y, Hu W, Yang BB. beta-Integrin-collagen interaction reduces chondiocyte apoptosis. Matrix Biol 1999;18:343-355.
42. Sabatini M, Rolland G, Leonce S, Thomas M, Lesur C, Perez V, de Nanteuil G, Bonnet J. Effects of ceramide on apoptosis, proteoglycan degradation, and matrix metalloproteinase expression in rabbit articular cartilage. Biochem Biophys Res Commun 2000;267:438-444.
43. Kim HA, Suh DI, Song YW. Relationship between chondrocyte apoptosis and matrix depletion in human articular cartilage. J Rheumatol 2001;28:2038-2045.
44. Masuda H, Asahara T. Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc Res 2003;58:390-398.
45. Vacanti JP, Morse MA, Saltzman WM, Domb AJ, Perez-Atayde A, Langer RJ. Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg 1988;23:3-9.